Latest news
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:12:00 GMTUS FDA to hold advisory meeting to review Grail’s multi-cancer test - WSAUWSAU · Fri, 07 Aug 2026 21:43:22 GMTFDA panel to review Grail's blood-based cancer test - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 21:32:11 GMTOne of Italy's Most Popular Attractions, the Uffizi Galleries in Florence, Reveals Plans for a Major Renovation Over the Next Two Years - Smithsonian MagazineSmithsonian Magazine · Fri, 07 Aug 2026 18:22:09 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTWhat’s in Tehran art galleries - Tehran TimesTehran Times · Fri, 07 Aug 2026 17:23:22 GMTGRAIL to face FDA AdCom for Galleri cancer test (GRAL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:43:36 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMT